Photo of Tommy Tobin

Thomas Tobin’s practice focuses on complex commercial litigation and class action matters involving statutory, constitutional, and regulatory issues in a range of industries, including food and beverage, consumer packaged goods, and cannabis. In the food and beverage sector, Tommy has experience defending false advertising claims and consumer protection claims for well-known international corporations.

Cannabis: In Focus

  • New York State Regulators Approve Final Adult-Use Regulations as Judge Bars New York State From Issuing New Cannabis Licenses
  • California Attorney General Partners With Cities To Address Illicit Cannabis Businesses
  • USDA Hemp Industry Updates


Continue Reading Cannabis Legal Report – Week of September 11, 2023

Cannabis: In Focus

  • VA Continues to Prohibit Doctors from Prescribing Cannabis to Veteran Patients
  • NY Judge Issues Court Order to Halt Cannabis Business Licensing
  • DEA Email Suggests DEA Considers Delta-8 THC a Controlled Substance
  • THC Testing Class Action Claims Proceed against Cannabis Company


Continue Reading Cannabis Legal Report – Week of August 14, 2023

Cannabis: In Focus

  • Congressional Activity—New Hearing and Bipartisan Bill on Hemp
  • Vermont Cannabis Cultivators Refused Federal Relief After Floods
  • DEA to Request Timeline for Administration’s Scheduling Review of Cannabis


Continue Reading Cannabis Legal Report—Week of August 7, 2023

On July 12, 2023, the U.S. Food and Drug Administration (FDA) released a public inventory of certain food ingredients that the agency has determined are unsafe because they are unapproved food additives that are not Generally Recognized as Safe (GRAS) when used as intended. FDA developed this inventory as part of its post-market surveillance of

Cannabis: In Focus

  • FDA and FTC Issue Cease and Desist Letters to Companies Selling Delta-8 Edibles
  • FDA Releases Draft Guidance for Psychedelic Drug Research
  • Federal Agencies Investigating Former Oregon Secretary of State’s Ties to Cannabis Company
  • “Plain” Packaging Guidelines for Missouri Cannabis Products Go Into Effect July 30


Continue Reading Cannabis Legal Report—Week of July 17, 2023

Cannabis: In Focus

  • DEA Announces New Guidance for Synthetic Cannabinoids
  • Oregon To Hold Landowners Responsible for Illegal Cannabis Grow Operations
  • States Provide State-Level Tax Relief to Cannabis Businesses
  • D.C. Superior Court Rules Cannabis Odor Constituted a Nuisance
  • New Suit Alleges Illicit Cannabis Operations Harm State-Legal Retailers


Continue Reading Cannabis Legal Report—Week of June 19, 2023

Cannabis: In Focus

  • Coalition Forms To Influence Scheduling Review Process
  • FDA Holds Stakeholder Call on CBD Regulation
  • New York Cannabis Regulators Settle Cannabis Licensing Suit
  • Minnesota Legalizes Adult-Use Cannabis
  • Maryland Releases Adult-Use Cannabis Regulations


Continue Reading Cannabis Legal Report—Week of June 5, 2023

As the Biden administration actively reviews the classification of cannabis under the Controlled Substances Act (CSA), a diverse group of cannabis companies and organizations is partnering with scientific and legal authorities, including Perkins Coie LLP, to launch the Coalition for Cannabis Scheduling Reform (CCSR).

The current classification of cannabis as a Schedule I drug puts

Cannabis: In Focus

  • SAFE Banking Gets a Senate Hearing
  • Representative Nancy Mace Is Promised a Hearing on her Descheduling Bill
  • CLAIM Act Reintroduced in Congress
  • Hawaii Federal Judge Says 11th Amendment Protects State’s Choice to Define Hemp
  • Maryland Governor Signs Cannabis Regulation Bill


Continue Reading Cannabis Legal Report—Week of May 8, 2023